vaccines

Moderna’s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday, sending the company’s shares surging more than 26%. Each participant was assigned to receive a 25 microgram, 100 mcg or 250 mcg dose, with 15 people in each dose group. Study participants received two doses of the potential vaccine…

President Donald Trump has suggested multiple times that a coronavirus vaccine could come within months, an accelerated timeline that prominent health experts and veteran vaccine developers say is unlikely absent a miracle. “We’re looking to get it by the end of the year if we can, maybe before,” Trump said Friday during in a Rose Garden event centered on his administration’s efforts...

President Donald Trump announced on Friday that Moncef Slaoui, a former GlaxoSmithKline executive, and Army Gen. Gustave Perna, the commander of United States Army Materiel Command, would lead the new initiative.

Pfizer has begun testing an experimental vaccine to combat the coronavirus in the United States, the pharmaceutical giant announced Tuesday. The U.S.-based company, which is working alongside German drugmaker BioNTech, said the first human participants in the United States have been dosed with the potential vaccine, BNT162. They began human trials of the experimental vaccine late last month in Germany. “With our...

U.S. researchers have opened another safety test of an experimental COVID-19 vaccine, this one using a skin-deep shot instead of the usual deeper jab.

Doctors and researchers hope to deliver a coronavirus vaccine to the American public sometime in the first half of 2021, but new poll findings indicate the bigger public health challenge may be convincing skeptical Americans to obtain a COVID-19 vaccine. A majority of U.S. adults (75%) said in a new LX/Morning Consult poll they’d likely get a coronavirus vaccine,...